We identified 49 genes (10.6%) concurrently upregulated and 168 genes (20.1%) concurrently downregulated in ARID1A‐mutant and ARID1B‐high breast cancer samples (Figure S2D,E, Supporting Information). This evidence concerns the gene ARID1B and breast carcinoma.